Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine

被引:4
作者
Schuler, Martin J. [1 ]
Becker, Dustin [1 ]
Mueller, Matteo [2 ]
Bautista Borrego, Lucia [2 ]
Mancina, Leandro [2 ]
Huwyler, Florian [3 ]
Binz, Jonas [1 ]
Hagedorn, Catherine [2 ]
Schaer, Beatrice [4 ]
Gygax, Erich [5 ]
Weisskopf, Miriam [6 ]
Sousa Da Silva, Richard Xavier [2 ]
Antunes Crisostomo, Joao Miguel [1 ]
Dutkowski, Philipp [2 ]
Rudolf von Rohr, Philipp [7 ]
Clavien, Pierre-Alain [2 ]
Tibbitt, Mark W. [3 ]
Eshmuminov, Dilmurodjon [2 ]
Hefti, Max [1 ]
机构
[1] Univ Zurich, Wyss Zurich ETH Zurich, CH-8092 Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Surg, Swiss Hepato Pancreato Biliary & Transplantat Ctr, Zurich, Switzerland
[3] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Macromol Engn Lab, Zurich, Switzerland
[4] Securecell AG, Entwicklung Biomed Anwendungen, Urdorf, Switzerland
[5] Fumed AG, Forsch & Entwicklung, Muri, Switzerland
[6] Univ Zurich, Univ Zurich Hosp, Surg Res Ctr, Zurich, Switzerland
[7] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Transport Proc & React Lab, Zurich, Switzerland
关键词
clearance; free hemoglobin; hemolysis; lactate; liver perfusion; long-term perfusion; perfusion parameters; subnormothermic; normothermic perfusion; CARDIOPULMONARY BYPASS; BLOOD; TRANSPLANTATION; PRESERVATION; METABOLISM; PULSATILE; MICROCIRCULATION; HEMOGLOBIN; DELIVERY; ORGAN;
D O I
10.1111/aor.14403
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background Ex situliver machine perfusion at subnormothermic/normothermic temperature isincreasingly applied in the field of transplantation to store and evaluateorgans on the machine prior transplantation. Currently, various perfusionconcepts are in clinical and preclinical applications. Over the last 6 years ina multidisciplinary team, a novel blood based perfusion technology wasdeveloped to keep a liver alive and metabolically active outside of the bodyfor at least one week. Methods Within thismanuscript, we present and compare three scenarios (Group 1, 2 and 3) we werefacing during our research and development (R&D) process, mainly linked tothe measurement of free hemoglobin and lactate in the blood based perfusate. Apartfrom their proven value in liver viability assessment (ex situ), these twoparameters are also helpful in R&D of a long-term liver perfusion machine and moreover supportive in the biomedical engineering process. Results Group 1 ("good" liver on the perfusion machine) represents the best liver clearance capacity for lactate and free hemoglobin wehave observed. In contrast to Group 2 ("poor" liver on the perfusion machine), that has shown the worst clearance capacity for free hemoglobin. Astonishingly,also for Group 2, lactate is cleared till the first day of perfusion andafterwards, rising lactate values are detected due to the poor quality of theliver. These two perfusate parametersclearly highlight the impact of the organ quality/viability on the perfusion process. Whereas Group 3 is a perfusion utilizing a blood loop only (without a liver). Conclusion Knowing the feasible ranges (upper- and lower bound) and the courseover time of free hemoglobin and lactate is helpful to evaluate the quality ofthe organ perfusion itself and the maturity of the developed perfusion device. Freehemoglobin in the perfusate is linked to the rate of hemolysis that indicates how optimizing (gentle blood handling, minimizing hemolysis) the perfusion machine actually is. Generally, a reduced lactate clearancecapacity can be an indication for technical problems linked to the blood supplyof the liver and therefore helps to monitor the perfusion experiments.Moreover, the possibility is given to compare, evaluate and optimize developed liverperfusion systems based on the given ranges for these two parameters. Otherresearch groups can compare/quantify their perfusate (blood) parameters withthe ones in this manuscript. The presented data, findings and recommendations willfinally support other researchers in developing their own perfusion machine ormodifying commercially availableperfusion devices according to their needs.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [41] Ex situ arterial reconstruction prior normothermic machine perfusion of liver grafts
    Becker, Felix
    Kneifel, Felicia
    Riegel, Arne
    Katou, Shadi
    Wagner, Tristan
    Flammang, Isabelle
    Juratli, Mazen
    Vogel, Thomas
    Radunz, Sonia
    Morgul, Haluk
    Pascher, Andreas
    Houben, Philipp
    Brockmann, Jens G.
    LANGENBECKS ARCHIVES OF SURGERY, 2022, 407 (08) : 3833 - 3841
  • [42] Deceased donor kidney function and branched chain amino acid metabolism during ex vivo normothermic perfusion
    Ahmadi, Armin
    Yu, Jacquelyn
    Loza, Jennifer E.
    Howard, Brian C.
    Palma, Ivonne
    Goussous, Naeem
    Sageshima, Junichiro
    Roshanravan, Baback
    Perez, Richard V.
    KIDNEY INTERNATIONAL, 2024, 106 (04) : 712 - 722
  • [43] Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content
    Raigani, Siavash
    Carroll, Cailah
    Griffith, Stephanie
    Pendexter, Casie
    Rosales, Ivy
    Deirawan, Hany
    Beydoun, Rafic
    Yarmush, Martin
    Uygun, Korkut
    Yeh, Heidi
    PLOS ONE, 2020, 15 (05):
  • [44] A Comparison of Pulsatile Hypothermic and Normothermic Ex Vivo Machine Perfusion in a Porcine Kidney Model
    Vallant, Natalie
    Wolfhagen, Nienke
    Sandhu, Bynvant
    Hamaoui, Karim
    Cook, Terence
    Pusey, Charles
    Papalois, Vassilios
    TRANSPLANTATION, 2021, 105 (08) : 1760 - 1770
  • [45] Application of polymerized porcine hemoglobin in the ex vivo normothermic machine perfusion of rat livers
    Li, Bin
    Zhang, Jie
    Shen, Chuanyan
    Zong, Tingting
    Zhao, Cong
    Zhao, Yumin
    Lu, Yunhua
    Sun, Siyue
    Zhu, Hongli
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [46] Normothermic Ex Vivo Liver Perfusion Prevents Intrahepatic Platelet Sequestration After Liver Transplantation
    Kollmann, Dagmar
    Linares-Cervantes, Ivan
    Ganesh, Sujani
    Rosales, Roizar
    Hamar, Matyas
    Goto, Toru
    Urbanellis, Peter
    Tessandier, Nicolas
    Boilard, Eric
    Bruguera, Claudia
    Wiebe, Aryn
    Bartczak, Agata
    Yip, Paul
    Adeyi, Oyedele
    Selzner, Markus
    Selzner, Nazia
    TRANSPLANTATION, 2020, 104 (06) : 1177 - 1186
  • [47] Initial perfusate purification during subnormothermic machine perfusion for porcine liver donated after cardiac death
    Obara, Hiromichi
    Morito, Noriyuki
    Matsuno, Naoto
    Yoshikawa, Ryo
    Nakajo, Tetsuya
    Gochi, Mikako
    Otani, Masahide
    Shonaka, Tatsuya
    Furukawa, Hiroyuki
    Hirano, Toshihiko
    Enosawa, Shin
    JOURNAL OF ARTIFICIAL ORGANS, 2020, 23 (01) : 62 - 69
  • [48] Kinetics of lactate metabolism during acellular normothermic ex vivo lung perfusion
    Koike, Terumoto
    Yeung, Jonathan C.
    Cypel, Marcelo
    Rubacha, Matthew
    Matsuda, Yasushi
    Sato, Masaaki
    Waddell, Thomas K.
    Liu, Mingyao
    Keshavjee, Shaf
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12) : 1312 - 1319
  • [49] Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers
    Matton, Alix P. M.
    Selten, Jasmijn W.
    Roest, Henk P.
    de Jonge, Jeroen
    IJzermans, Jan N. M.
    de Meijer, Vincent E.
    Porte, Robert J.
    van der Laan, Luc J. W.
    CLINICAL TRANSPLANTATION, 2020, 34 (03)
  • [50] Ex vivo machine perfusion: current applications and future directions in liver transplantation
    Michelotto, Julian
    Gassner, Joseph M. G. V.
    Moosburner, Simon
    Muth, Vanessa
    Patel, Madhukar S.
    Selzner, Markus
    Pratschke, Johann
    Sauer, Igor M.
    Raschzok, Nathanael
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (01) : 39 - 54